The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review of proposed biological mechanisms without systematic search methodology or original clinical data
PubMed 25981208 · doi:10.1016/j.neuroscience.2015.05.018
What was done
This narrative review synthesized literature examining the involvement of systemic inflammation, oxidative stress, and central microglial activation in the pathophysiology of major psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BD), schizophrenia, and autism. The authors specifically focused on molecular cascades involving pro-inflammatory M1 microglial activation (producing IL-1β and TNF-α) versus anti-inflammatory M2 microglial states.
What was found
The abstract does not provide quantitative data, effect sizes, or study counts. It qualitatively notes that increased peripheral inflammatory responses and oxidative stress can trigger microglial activation in the central nervous system. Activation of the M1 phenotype leads to release of pro-inflammatory cytokines (IL-1β, TNF-α), whereas the M2 phenotype releases anti-inflammatory cytokines, suggesting neuroinflammatory pathways may drive brain pathology and alter psychiatric treatment response.
Why it matters
Synthesizing how neuroimmune mechanisms relate to psychiatric phenotypes helps frame psychiatric conditions as systemic and neuroinflammatory disorders, highlighting microglia as potential targets for therapeutic intervention.
Limits
The abstract describes a narrative review rather than a systematic review or meta-analysis, with no details on study selection criteria, sample sizes, or quantitative outcomes. Causality cannot be determined from the summarized observational and mechanistic associations, and the exact clinical relevance across distinct psychiatric conditions remains unquantified.
Cited by
- supports Brain inflammation is a common biological denominator observed across conditions such as schizophrenia, autism, major depression, and bipolar disorder.